-
Something wrong with this record ?
Proteomic analysis revealed the survival strategy of Coxiella burnetii to doxycycline exposure
F. Zuñiga-Navarrete, G. Flores-Ramirez, M. Danchenko, O. Benada, A. Skriba, L. Skultety,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Drug Resistance, Bacterial drug effects MeSH
- Coxiella burnetii metabolism MeSH
- Doxycycline pharmacology MeSH
- Microbial Viability drug effects MeSH
- Proteomics MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Antibiotic resistance is a global threat with a top concern in healthcare. Doxycycline is an antibiotic highly permeable to cell membrane used for treating a broad variety of bacteria, including Coxiella burnetii. This intracellular pathogen is the causative agent of Q fever, a re-emerging zoonosis found worldwide. Hence, C. burnetii has a considerable impact on the farming industry and public health, it is essential to explore its antibiotic adaptation/tolerance strategy to ensure effective therapy. Herein, we tracked changes in the bacterium induced by doxycycline exposure. Our proteomic analysis detected fifteen significantly altered proteins. Adjustments of some key proteins were verified by gene expression analysis. We also observed an increasing in hydrogen peroxide as a consequence of treatment, indicating deregulation of redox balance. Thus, our data suggests the reduction of protein synthesis to minimal levels, activation of the defense mechanism against oxidative stress and maintenance of cell envelope integrity as the key processes ensuring C. burnetii survival under doxycycline exposure. SIGNIFICANCE: Infection by intracellular microorganisms like C. burnetii requires long periods of treatment, thus antibiotic resistance development is a risk. In this report, 2-DE quantitative proteomics was used to identify changes in the proteome that occurs when C. burnetii is exposed to high concentrations of doxycycline. The identification of pathways impacted by doxycycline could be helpful to understand the mechanism of how C. burnetii is dealing with antibiotic stress.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025644
- 003
- CZ-PrNML
- 005
- 20201222160319.0
- 007
- ta
- 008
- 201125s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jprot.2019.103479 $2 doi
- 035 __
- $a (PubMed)31394312
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Zuñiga-Navarrete, Fernando $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia.
- 245 10
- $a Proteomic analysis revealed the survival strategy of Coxiella burnetii to doxycycline exposure / $c F. Zuñiga-Navarrete, G. Flores-Ramirez, M. Danchenko, O. Benada, A. Skriba, L. Skultety,
- 520 9_
- $a Antibiotic resistance is a global threat with a top concern in healthcare. Doxycycline is an antibiotic highly permeable to cell membrane used for treating a broad variety of bacteria, including Coxiella burnetii. This intracellular pathogen is the causative agent of Q fever, a re-emerging zoonosis found worldwide. Hence, C. burnetii has a considerable impact on the farming industry and public health, it is essential to explore its antibiotic adaptation/tolerance strategy to ensure effective therapy. Herein, we tracked changes in the bacterium induced by doxycycline exposure. Our proteomic analysis detected fifteen significantly altered proteins. Adjustments of some key proteins were verified by gene expression analysis. We also observed an increasing in hydrogen peroxide as a consequence of treatment, indicating deregulation of redox balance. Thus, our data suggests the reduction of protein synthesis to minimal levels, activation of the defense mechanism against oxidative stress and maintenance of cell envelope integrity as the key processes ensuring C. burnetii survival under doxycycline exposure. SIGNIFICANCE: Infection by intracellular microorganisms like C. burnetii requires long periods of treatment, thus antibiotic resistance development is a risk. In this report, 2-DE quantitative proteomics was used to identify changes in the proteome that occurs when C. burnetii is exposed to high concentrations of doxycycline. The identification of pathways impacted by doxycycline could be helpful to understand the mechanism of how C. burnetii is dealing with antibiotic stress.
- 650 _2
- $a Coxiella burnetii $x metabolismus $7 D016997
- 650 _2
- $a doxycyklin $x farmakologie $7 D004318
- 650 _2
- $a bakteriální léková rezistence $x účinky léků $7 D024881
- 650 _2
- $a mikrobiální viabilita $x účinky léků $7 D050296
- 650 _2
- $a proteomika $7 D040901
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Flores-Ramirez, Gabriela $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia. Electronic address: virugafl@savba.sk.
- 700 1_
- $a Danchenko, Maksym $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia. Electronic address: maksym.danchenko@savba.sk.
- 700 1_
- $a Benada, Oldrich $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnská 1083, 142 20 Prague, Czech Republic. Electronic address: benada@biomed.cas.cz.
- 700 1_
- $a Skriba, Anton $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnská 1083, 142 20 Prague, Czech Republic. Electronic address: anton.skriba@biomed.cas.cz.
- 700 1_
- $a Skultety, Ludovit $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia; Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnská 1083, 142 20 Prague, Czech Republic. Electronic address: viruludo@savba.sk.
- 773 0_
- $w MED00166847 $t Journal of proteomics $x 1876-7737 $g Roč. 208, č. - (2019), s. 103479
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31394312 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160315 $b ABA008
- 999 __
- $a ok $b bmc $g 1599789 $s 1116330
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 208 $c - $d 103479 $e 20190805 $i 1876-7737 $m Journal of proteomics $n J Proteomics $x MED00166847
- LZP __
- $a Pubmed-20201125